PE20210839A1 - Metodo de produccion de un compuesto intermedio para sintetizar un medicamento - Google Patents

Metodo de produccion de un compuesto intermedio para sintetizar un medicamento

Info

Publication number
PE20210839A1
PE20210839A1 PE2020000586A PE2020000586A PE20210839A1 PE 20210839 A1 PE20210839 A1 PE 20210839A1 PE 2020000586 A PE2020000586 A PE 2020000586A PE 2020000586 A PE2020000586 A PE 2020000586A PE 20210839 A1 PE20210839 A1 PE 20210839A1
Authority
PE
Peru
Prior art keywords
synthesize
production
intermediate compound
medicinal product
chemical formula
Prior art date
Application number
PE2020000586A
Other languages
English (en)
Inventor
Jongwon Park
Seok Ju Lee
In Ae Ryu
Bongchan Kim
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Priority claimed from PCT/KR2018/012575 external-priority patent/WO2019098551A1/ko
Publication of PE20210839A1 publication Critical patent/PE20210839A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02—Monohydroxylic acyclic alcohols
    • C07C31/04—Methanol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/12—Saturated polycyclic compounds
    • C07C61/125—Saturated polycyclic compounds having a carboxyl group bound to a condensed ring system
    • C07C61/13—Saturated polycyclic compounds having a carboxyl group bound to a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/10—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a un metodo de preparacion de formula quimica 1 que es un producto intermedio necesario para sintetizar antidiabeticos que inhiben la DPP-IV desprotegiendo selectivamente el grupo protector de acido carboxilico (P2) del compuesto de formula quimica 2.
PE2020000586A 2017-11-16 2018-10-23 Metodo de produccion de un compuesto intermedio para sintetizar un medicamento PE20210839A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20170153334 2017-11-16
PCT/KR2018/012575 WO2019098551A1 (ko) 2017-11-16 2018-10-23 의약품 합성용 중간체 화합물의 제조 방법
KR1020180126663A KR102184129B1 (ko) 2017-11-16 2018-10-23 의약품 합성용 중간체 화합물의 제조 방법

Publications (1)

Publication Number Publication Date
PE20210839A1 true PE20210839A1 (es) 2021-05-06

Family

ID=66680122

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2020000586A PE20210839A1 (es) 2017-11-16 2018-10-23 Metodo de produccion de un compuesto intermedio para sintetizar un medicamento

Country Status (8)

Country Link
KR (1) KR102184129B1 (es)
CN (1) CN111247127B (es)
BR (1) BR112020009568A2 (es)
CL (1) CL2020001285A1 (es)
CO (1) CO2020006788A2 (es)
PE (1) PE20210839A1 (es)
PH (1) PH12020550635A1 (es)
RU (1) RU2741389C1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2721185A1 (de) * 1977-05-11 1978-11-16 Bayer Ag Verfahren zur herstellung von substituierten vinylcyclopropancarbonsaeurebenzylestern
JPH04316526A (ja) * 1991-04-15 1992-11-06 Asahi Chem Ind Co Ltd カルボン酸エステルのアルカリ加水分解法
TW460452B (en) * 1998-09-14 2001-10-21 Rhodia Fiber & Amp Resin Inter Process for the crystallization of carboxylic acid and process for manufacturing crystalline carboxylic acid
TWI357902B (en) * 2005-04-01 2012-02-11 Lg Life Science Ltd Dipeptidyl peptidase-iv inhibiting compounds, meth
JP2008201719A (ja) * 2007-02-20 2008-09-04 Nippon Oil Corp テトラカルボン酸およびその酸二無水物の製造方法
JP5358585B2 (ja) * 2007-12-21 2013-12-04 エルジー ライフ サイエンス リミテッド ジペプチジルペプチダーゼ−ｉｖ阻害化合物、同化合物を製造する方法、及び活性剤として同化合物を含む医薬組成物
SG188329A1 (en) * 2010-09-03 2013-04-30 Lg Life Sciences Ltd Production method of intermediate compound for synthesizing medicament

Also Published As

Publication number Publication date
CN111247127A (zh) 2020-06-05
RU2741389C1 (ru) 2021-01-25
KR20190056296A (ko) 2019-05-24
PH12020550635A1 (en) 2021-02-22
BR112020009568A2 (pt) 2021-03-09
CO2020006788A2 (es) 2020-06-09
CL2020001285A1 (es) 2020-10-23
CN111247127B (zh) 2024-02-06
KR102184129B1 (ko) 2020-11-27

Similar Documents

Publication Publication Date Title
CY1123521T1 (el) Νεες ενωσεις και φαρμακευτικες συνθεσεις αυτων για την αγωγη φλεγμονωδων διαταραχων
NI201800093A (es) Inhibidores de mcl1 macrocíclicos para tratar el cáncer
TN2018000043A1 (en) Novel 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitors
UY32025A (es) Derivados sustituídos de la 6-cloro-2-hidroxi-3-(3,4-dioxo-ciclobut-1-enil-amino)-n-metoxi-n-metil-bencen-sulfonamida, solvatos, hidratos o sales farmacéuticamente aceptables de los mismos, proceso de preparación, composiciones y aplicaciones.
SG11201906688VA (en) Novel ester compounds, method for the production thereof and use thereof
CO2020001927A2 (es) Método de producción de composiciones farmacéuticas que comprende el virus chikungunya inmunogénico chikv-delta5nsp3
MX2017008431A (es) Compuestos ciclicos sustituidos con un sistema de anillos condensado.
WO2016038628A3 (en) A process for preparing olodaterol and intermediates thereof
JOP20170172B1 (ar) أملاح إضافة لحمض من مشتق بنزيميدازول
ES2721662T3 (es) Proceso para la preparación de travoprost
MX2017001459A (es) Sintesis de fosforamidatos.
IN2014DN10617A (es)
BR112015016924A2 (pt) método para a preparação do composto de piripiropeno
MX2017015662A (es) Procesos para la preparacion de derivados acidos de n-acetilgalactosamina (galnac).
BR112017019850A2 (pt) ?processo melhorado para a preparação de apremilast?
BR112019001447A2 (pt) método de produção para composto pirazol-amida
WO2016142819A3 (en) Novel process for the preparation of ranolazine
BR112018007505A2 (pt) processo industrial para a preparação de sal de (e)-3-carboxiacrilato de (5s,10s)-10-benzil-16-metil-11,14,18-trioxo-15,17,19-trioxa-2,7,8-tritia-12-aza-henicosan-5-amínio
PE20210839A1 (es) Metodo de produccion de un compuesto intermedio para sintetizar un medicamento
CO2021001857A2 (es) Preparación de intermedio útil para la síntesis de inhibidor de sglt
BR112018074287A2 (pt) processo para preparação de eribulina e intermediários da mesma
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds
BR112015021151A2 (pt) processo para a preparação de (2s,5r)-ácido sulfúrico mono-{[(4-aminopiperidin-4-il)carbonil]-7-oxo-1,6-diazabiciclo[3.2.1]-oct-6-il} éster
MX2021001530A (es) Metodo de produccion de esteres carbonicos.
MX2020005099A (es) Metodo de produccion de un compuesto intermedio para sintetizar un medicamento.